The use and safety of XGEVA or Zoledronic acid in clinical practice among Chinese patients with bone metastases from breast, lung, or prostate cancer – a retrospective cohort study within Taiwan’s Health Insurance Research Database (20190412) First published 12/03/2021 Last updated 02/07/2024 EU PAS number:EUPAS39611 Study Finalised